How Is Non-Hodgkin Lymphoma Diagnosed? Tests, Criteria & Process
Non-Hodgkin Lymphoma diagnosis relies on Tissue biopsy (histopathology + immunohistochemistry), CT/PET-CT staging scan, Tumour markers (PSA, CA-125, CEA, AFP, CA 19-9). Learn the full diagnostic pathway, clinical criteria, differential workup, and what to expect at your evaluation.
Updated March 27, 2026
Non-Hodgkin Lymphoma is diagnosed using Tissue biopsy (histopathology + immunohistochemistry), CT/PET-CT staging scan, Tumour markers (PSA, CA-125, CEA, AFP, CA 19-9) and targeted clinical evaluation. Non-Hodgkin lymphoma is a group of blood cancers affecting the lymphatic system, presenting with painless swollen lymph nodes, fatigue, night sweats, and weight loss. It is more common than Hodgkin lymphoma.
Clinical Context
The diagnostic process for Non-Hodgkin Lymphoma begins with Cross-sectional imaging for mass lesion detection; biopsy for histological confirmation; staging workup before MDT treatment decision. Key investigations include Tissue biopsy (histopathology + immunohistochemistry), CT/PET-CT staging scan, Tumour markers (PSA, CA-125, CEA, AFP, CA 19-9), Full blood count and peripheral blood film. The gold standard is: Tissue biopsy is the gold standard for all malignancies; bone marrow trephine for haematological staging. Clinical guidelines from ESMO / ASCO / NCCN / ASH / NICE Oncology define the diagnostic criteria and recommended investigation pathway.
How Doctors Confirm the Diagnosis in Practice
Updated March 27, 2026How Is Non-Hodgkin Lymphoma Diagnosed? Tests, Criteria & Process usually becomes clinically useful only when the symptom pattern is read in context rather than as a single isolated phrase. On real pages, people search this question when they are trying to separate benign explanations from higher-risk causes such as Non-Hodgkin Lymphoma. The symptom becomes more meaningful when it appears together with associated symptoms, because that combination changes which diagnoses move higher on the differential and which ones can be deprioritised. That is why this page now reinforces the diagnostic path with direct links to the strongest canonical symptom and condition hubs, so Google and users can see a clearer entity relationship instead of another standalone FAQ fragment.
Clinical Pathway
Non-Hodgkin Lymphoma — Full Condition GuideCondition HubNon-Hodgkin Lymphoma — Differential DiagnosisDifferentialNon-Hodgkin Lymphoma — Treatment PathwaysTreatmentLeukemia vs. Non-Hodgkin Lymphoma — Comparisonvs.Non-Hodgkin Lymphoma — Prognosis & OutlookPrognosisFrequently Asked Questions
How Is Non-Hodgkin Lymphoma Diagnosed? Tests, Criteria & Process+
Non-Hodgkin Lymphoma is diagnosed using Tissue biopsy (histopathology + immunohistochemistry), CT/PET-CT staging scan, Tumour markers (PSA, CA-125, CEA, AFP, CA 19-9) and targeted clinical evaluation. Non-Hodgkin lymphoma is a group of blood cancers affecting the lymphatic system, presenting with painless swollen lymph nodes, fatigue, night sweats, and weight loss. It is more common than Hodgkin lymphoma.
What tests diagnose Non-Hodgkin Lymphoma?+
The main tests used to diagnose Non-Hodgkin Lymphoma include Tissue biopsy (histopathology + immunohistochemistry), CT/PET-CT staging scan, Tumour markers (PSA, CA-125, CEA, AFP, CA 19-9). Your doctor will select investigations based on your symptoms, clinical findings, and risk factors.
How long does it take to diagnose Non-Hodgkin Lymphoma?+
The time to diagnosis varies. Some cases are identified within hours using clinical presentation and blood tests; others require weeks, repeated investigations, or specialist referral.
Can Non-Hodgkin Lymphoma be missed on initial testing?+
Yes — Non-Hodgkin Lymphoma can be missed if initial tests are negative or if the presentation is atypical. If clinical suspicion remains high, repeat testing or specialist referral is appropriate.
Our AI Symptom Checker analyzes your symptoms and suggests possible conditions based on clinical guidelines.
Start Free Analysis →